Capienda is developing an advanced system (novel assay chemistry + bioanalytical instrument) to accelerate drug discovery in the pharmaceutical industry.
US Patent Application 63/038,042. METHODS AND SYSTEMS FOR HIGH-THROUGHPUT KINETIC ANALYSIS OF LIGAND-RECEPTOR INTERACTIONS
Capienda’s drug delivery technology is designed to target disease-relevant cells (while avoiding normal cells) and engages previously un-druggable targets.
PCT/US2019/025,207. COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY DISEASES